CEO: | Adrian Kinkaid |
Chairman: | Simon Gordon Douglas |
Chief Scientific Officer: | Richard John Buick |
Non-Executive Dir: | Colin Walsh, Matthew Baker |
Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
Website: | https://www.fusionantibodies.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BDQZGK16 |
Currency | UK Pounds |
Share Price | 13.25p |
Change Today | -0.25p |
% Change | -1.85 % |
52 Week High | 18.75 |
52 Week Low | 4.00 |
Volume | 1,488,166 |
Shares Issued | 113.66m |
Market Cap | £15.06m |
RiskGrade | 464 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:00 | 136,040 @ 13.18p |
15:40 | 50,000 @ 13.12p |
15:36 | 84,000 @ 13.44p |
14:35 | 100,591 @ 13.55p |
14:34 | 125,000 @ 13.56p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research